• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Special Reports
  • Technologies
    • Artificial Intelligence (AI)
    • Cardiovascular
    • Orthopedics
    • Neurological
    • Diabetes
    • Surgical Robotics
  • Business & Finance
    • Wall Street Beat
    • Earnings Reports
    • Funding Roundup
    • Mergers & Acquisitions
    • Initial Public Offering (IPO)
    • Legal News
    • Personnel Moves
    • Medtech 100 Stock Index
  • Regulatory
    • Food & Drug Administration (FDA)
    • Recalls
    • 510(k)
    • Pre-Market Approval (PMA)
    • MDSAP
    • Clinical Trials
  • Resources
    • About MassDevice
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech100 Index
    • Videos
    • Webinars
    • Whitepapers
    • Voices
    • In-Depth Coverage
    • Latest News
  • Attend DeviceTalks
    • Events
      • DeviceTalks Minnesota – May 4
      • DeviceTalks Boston – May 27–28
      • DeviceTalks West
      • DeviceTalks Tuesdays
    • DeviceTalks Podcast Network
      • DeviceTalks Weekly
      • AbbottTalks
      • Boston ScientificTalks
      • DeviceTalks AI
      • IntuitiveTalks
      • MedtechWOMEN Talks
      • MedtronicTalks
      • Neuro Innovation Talks
      • Ortho Innovation Talks
      • Structural Heart Talks
      • StrykerTalks
  • Advertise
  • Subscribe
Home » Stryker CEO: Medical device tax is ‘a job-killing bill’

Stryker CEO: Medical device tax is ‘a job-killing bill’

September 7, 2012 By MassDevice staff

Stryker

Stryker (NYSE:SYK) is expecting the medical device tax contained in President Barack Obama’s healthcare reform law to cost it roughly $130 million a year, according to interim CEO Curt Hartman.

During the Kalamazoo, Mich.-based medical device company’s annual analyst day in Mahwah, N.J., yesterday, Hartman called the 2.3% excise tax "the elephant in the room."

"There’s been wide discussion around what the impact will be on various companies. I would tell you right now, we have communicated that our impact would be somewhere in the [$130 million] range," he said.

To offset that, Hartman said, Stryker and its peers will likely move significant portions of their operations overseas. That’s because of a provision in the tax, which is set to go into effect Jan. 1, 2013, that applies the levy to medical devices that are shipped to trade shows or sent as loaners or replacements, he explained.

"[Y]ou take a product to a trade show, you have to pay the med-device tax on that product," Hartman said, citing the example of a customer sending a device back for repair. "We have to pay a 2.3% med-device tax every time we ship that loaner out the door.

Curt Hartman, interim CEO, Strykler Corp.

Hartman

"So from a slightly political statement, it is a job-killing bill," he said. "If I want to minimize my tax, I ask [Stryker global quality & operations president] Lonny Carpenter to move all U.S. manufacturing outside the U.S. and set up an arm’s-length transaction at cost plus, and then pay my med-device tax when it crosses the border. There’s been great discussion on this exact point in Washington, D.C. Stryker and other med-tech companies have been very involved in that [discussion]."

The November election will play a role in how the tax shakes out, Hartman said, adding that although the legislation is still in draft form most med-tech companies are preparing for it’s implementation.

"Who knows where the election takes it? There’s a lot of dialogue in D.C. about the device tax getting caught up in comprehensive corporate tax reform next year, or it could get pushed out and delayed," he said. "What we’re doing, and every other player in the industry is doing, is putting the systems in place assuming the Jan. 1 start, because that’s the rule and regulation that’s on the books right now."

Filed Under: News Well Tagged With: Stryker

More recent news

  • FDA warns of Philips ultrasound issues after four patient deaths
  • FDA approves Gore bridging stent graft in complex aortic aneurysms
  • Steris inks $2.1B deal for operating room supplier Xodus Medical
  • Insulet’s Omnipod Discover data platform begins full US rollout
  • Siemens Healthineers exits general ultrasound to focus on cardiac imaging

Primary Sidebar

“md
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest med device regulatory, business and technology news.

DeviceTalks Weekly

See More >
MDO ad
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World
Medical Design Sourcing

DeviceTalks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our DeviceTalks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us

Copyright © 2026 · Arrowfly LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of Arrowfly.

Privacy Policy